Search results
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 6 days agoModerna has a couple of factors to back its strong run. Firstly, the U.S. FDA recently approved ...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 6 days agoThe submission is based on FDA guidance, which advised that COVID-19 vaccines should be updated to a...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 3 days agoModerna also expects to report results from a phase 3 study of its combination flu-COVID vaccine later this year. Meanwhile, Moderna is evaluating its...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 2 days agoThe transactions, which took place on June 11, 2024, resulted in the sale of Moderna stock worth...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 3 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
Why Moderna Stock Is a No-Brainer Buy Right Now
The Motley Fool via AOL· 3 days agoModerna also expects to report results from a phase 3 study of its combination flu-COVID vaccine later this year. Meanwhile, Moderna is evaluating its cytomegalovirus ...
Moderna Combination Shot Outperforms Standalone Flu, Covid-19 Jabs
Barrons.com· 3 days agoThe results could to upend the flu market if they withstand scrutiny from regulators. More than half...
Daily Brief: Apple’s AI strategy
Quartz· 3 days ago“Apple Intelligence” is a new collection of AI features that is focused on personal products, and privacy is a huge goal of executives.
Why Moderna Stock Is a No-Brainer Buy Right Now | The Motley Fool
The Motley Fool· 3 days agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only...
Connectus Wealth LLC Purchases 2,016 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 1 day agoReport) by 90.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,237 shares ...
